Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Wednesday, January 09, 2019
Selexis has signed additional CLAs with Agenus, an immuno-oncology company with a pipeline of immune-modulating antibodies, cancer vaccines, and adoptive cell therapies.
read more
Wednesday, January 09, 2019
Pii announced its partner, Academic Pharmaceuticals, received FDA approval of Bretylium Tosylate Injection USP, 500 mg/10 mL (50 mg/mL) Single-Dose Vials on December 21, 2018.
read more
Wednesday, January 09, 2019
AbSci will apply its breakthrough E.coli manufacturing platform, SoluPro, and its novel optimization assay system, to two of Sanofi's biotherapeutic molecules.
read more
Wednesday, January 09, 2019
PAREXEL has introduced a new, dedicated division to support emerging biotech companies in reaching their drug development and commercialization goals quickly and cost-effectively.
read more
Tuesday, January 08, 2019
Caprion Biosciences announced it is offering mass cytometry services to advance biomarker discovery and immune monitoring.
read more
Tuesday, January 08, 2019
ValGenesis announced that a manufacturer of Oral Rehydration Salts has chosen ValGenesis's paperless Validation Lifecycle Management System to manage its validation lifecycle process.
read more
Tuesday, January 08, 2019
Industrial wastewater treatment provider Axine Water Technologies has signed a multi-year wastewater services agreement with a pharmaceutical manufacturer.
read more
CytoReason has entered into a collaboration agreement with Pfizer that will leverage CytoReason’s cell-centered models of the immune system.
read more
Rentschler Biopharma announced the company has completed the acquisition of a manufacturing facility from an affiliate of Shire.
read more
Robert Broeze will retire on March 5th, 2019 after a 35-year career in the biopharmaceutical industry.
read more
Catalent has commenced a $200 million capital investment in its Biologics business to expand drug substance manufacturing capacity and drug product fill/finish capacity.
read more
Almac has brought a second stream for High Throughput GMP Peptide manufacturing online.
read more
Bioasis Technologies announced a joint research collaboration with a leading pharmaceutical company.
read more
Wednesday, January 02, 2019
Stem Cell Medicine has licensed an exosomes based technology for the treatment of neurodegenerative and neuropsychiatric indications, specifically, autism spectrum disorder.
read more
Wednesday, January 02, 2019
Cambrex has completed the acquisition of Avista Pharma Solutions, a contract development, manufacturing, and testing organization, from Ampersand Capital Partners.
read more